Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Lower urinary tract symptoms of neurological origin in urological practice.
Retinal Damage in Multiple Sclerosis Disease Subtypes Measured by High-Resolution Optical Coherence Tomography.
Effect of fingolimod (FTY720) on cerebral blood flow, platelet function, and macular thickness in healthy volunteers.
Up-regulated fractalkine (FKN) and its receptor CX3CR1 are involved in fructose-induced neuroinflammation: Suppression by curcumin.
Overview of the epidemiology, diagnosis, and disease progression associated with multiple sclerosis.
The induction of cell-mediated immunity and tolerance with protein antigens coupled to syngeneic lymphoid cells.
Hope for a rare disease: eculizumab in neuromyelitis optica.
Statins affect cell-surface expression of major histocompatibility complex class II molecules by disrupting cholesterol-containing microdomains.
Low vitamin D and elevated immunoreactivity against Epstein-Barr virus before first clinical manifestation of multiple sclerosis.
Damage to the optic chiasm in myelin oligodendrocyte glycoprotein-experimental autoimmune encephalomyelitis mice.
Exacerbation of experimental autoimmune encephalomyelitis after withdrawal of phenytoin and carbamazepine.
Labor induction and augmentation in women with multiple sclerosis.
An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis.
The Symbol Digit Modalities Test as sentinel test for cognitive impairment in multiple sclerosis.
FTY720 (Fingolimod) attenuates basal and sphingosine 1-phosphate-evoked thyroid cancer cell invasion.
B-89Comparison of Driving Performance, Cognition, and Physical Symptoms in Individuals with Multiple Sclerosis and Healthy Controls.
Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis.
Relapsing-Remitting Central Nervous System Autoimmunity Mediated by GFAP-Specific CD8 T Cells.
The impact of neutralizing antibodies on the risk of disease worsening in interferon β-treated relapsing multiple sclerosis: a 5 year post-marketing study.
Myelination of rodent hippocampal neurons in culture.
Reply to letter to the editor: "JC viremia and multiple sclerosis" by Focosi et al.
Nrf2 in health and disease: current and future clinical implications.
Expanded functional coupling of subcortical nuclei with the motor resting-state network in multiple sclerosis.
Behçet's disease patients with multiple sclerosis-like features: discriminative value of Barkhof criteria.
MRI criteria distinguishing seropositive NMO spectrum disorder from MS.
Pages
« first
‹ previous
…
206
207
208
209
210
211
212
213
214
…
next ›
last »